PIA
CASI

Piedmont Investment Advisors’s CASI Pharmaceuticals CASI Stock Holding History

Piedmont Investment Advisors’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-87
Closed -$7K – 1227
2018
Q2 		$7K Buy
+87
New +$5.87K ﹤0.01% 1960

Other funds holding CASI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Piedmont Investment Advisors's CASI Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of CASI Pharmaceuticals (CASI) in Q3 2018, closing a stake of 87 shares — an estimated $7K sold.

Piedmont Investment Advisors first reported a position in CASI in Q2 2018 and held it in 1 quarter. The position peaked at $7K in Q2 2018. 63 funds tracked by Wall St. Rank hold CASI as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining CASI Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 87 CASI Pharmaceuticals shares in Q3 2018, an estimated $7K.
  • Piedmont Investment Advisors first reported a position in CASI Pharmaceuticals in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's CASI Pharmaceuticals position peaked at $7K in Q2 2018.
  • 63 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.